Biodegradable polymer drug-eluting stents versus first-generation durable polymer drug-eluting stents
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference34 articles.
1. Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trial;Marchini;Cardiovasc Diagn Ther,2014
2. Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials;Piccolo;Clin Res Cardiol,2012
3. Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions;Cutlip;Circulation,2007
4. Nine-month angiographic and two-year clinical follow-up of novel biodegradable-polymer arsenic trioxide-elutingstent versus durable-polymer sirolimus-eluting stent for coronary artery disease;Shen;Chin Med J (Engl,2015
5. COSTAR II Investigators Group. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronarydisease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study;Krucoff;J Am Coll Cardiol,2008
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nanotechnology in development of next generation of stent and related medical devices: Current and future aspects;WIREs Nanomedicine and Nanobiotechnology;2024-03
2. Endovascular drug-delivery and drug-elution systems;Biomechanics of Coronary Atherosclerotic Plaque;2021
3. Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review;Molecules;2020-10-11
4. Biodegradable polymer versus second-generation durable polymer drug-eluting stents in patients with coronary artery disease: A meta-analysis;Health Science Reports;2018-10-05
5. Prevention of intimal hyperplasia by immobilized all-trans retinoic acid;Journal of Controlled Release;2018-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3